Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Scope of the Report:
This report studies the Transdermal Drug Delivery System market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transdermal Drug Delivery System market by product type and applications/end industries.
The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 is about 31.1%. Transdermal Drug Delivery System can be used for OTC, Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion is about 83.3% in 2016.
North America is the largest sales place, with a revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place with the revenue market share of 28%. China and Japan are also important sales regions for Transdermal Drug Delivery System.
The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.
Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Transdermal Drug Delivery System market is valued at 8950 million USD in 2017 and is expected to reach 19000 million USD by the end of 2023, growing at a CAGR of 13.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transdermal Drug Delivery System.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Market Segment by Applications, can be divided into
OTC
Rx
Table of Contents
1 Transdermal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System by Types
1.2.1 Global Transdermal Drug Delivery System Revenue Comparison by Types (2017-2023)
1.2.2 Global Transdermal Drug Delivery System Revenue Market Share by Types in 2017
1.2.3 Fentanyl
1.2.4 Nitroglycerin
1.2.5 Estradiol
1.2.6 Nicotine
1.2.7 Other
1.3 Global Transdermal Drug Delivery System Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 OTC
1.3.3 Rx
1.4 Global Transdermal Drug Delivery System Market by Regions
1.4.1 Global Transdermal Drug Delivery System Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Transdermal Drug Delivery System Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Transdermal Drug Delivery System Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transdermal Drug Delivery System Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Transdermal Drug Delivery System Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transdermal Drug Delivery System Status and Prospect (2013-2023)
1.5 Global Market Size of Transdermal Drug Delivery System (2013-2023)
2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Business Overview
2.1.2 Transdermal Drug Delivery System Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Transdermal Drug Delivery System Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
2.3.1 Business Overview
2.3.2 Transdermal Drug Delivery System Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Transdermal Drug Delivery System Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teve (Actavis)
2.5.1 Business Overview
2.5.2 Transdermal Drug Delivery System Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Transdermal Drug Delivery System Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.7 Lohmann
2.7.1 Business Overview
2.7.2 Transdermal Drug Delivery System Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teikoku Seiyaku
2.8.1 Business Overview
2.8.2 Transdermal Drug Delivery System Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer
2.9.1 Business Overview
2.9.2 Transdermal Drug Delivery System Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lingrui
2.10.1 Business Overview
2.10.2 Transdermal Drug Delivery System Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sanofi
2.11.1 Business Overview
2.11.2 Transdermal Drug Delivery System Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.12 Qizheng
2.12.1 Business Overview
2.12.2 Transdermal Drug Delivery System Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.13 Endo
2.13.1 Business Overview
2.13.2 Transdermal Drug Delivery System Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.14 Huarun 999
2.14.1 Business Overview
2.14.2 Transdermal Drug Delivery System Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.15 Haw Par
2.15.1 Business Overview
2.15.2 Transdermal Drug Delivery System Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.16 Nichiban
2.16.1 Business Overview
2.16.2 Transdermal Drug Delivery System Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.17 Mentholatum Company
2.17.1 Business Overview
2.17.2 Transdermal Drug Delivery System Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Mentholatum Company Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
2.18 Laboratoires Genevrier
2.18.1 Business Overview
2.18.2 Transdermal Drug Delivery System Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
3 Global Transdermal Drug Delivery System Market Competition, by Players
3.1 Global Transdermal Drug Delivery System Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Transdermal Drug Delivery System Players Market Share
3.2.2 Top 10 Transdermal Drug Delivery System Players Market Share
3.3 Market Competition Trend
4 Global Transdermal Drug Delivery System Market Size by Regions
4.1 Global Transdermal Drug Delivery System Revenue and Market Share by Regions
4.2 North America Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
4.3 Europe Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
4.5 South America Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
5 North America Transdermal Drug Delivery System Revenue by Countries
5.1 North America Transdermal Drug Delivery System Revenue by Countries (2013-2018)
5.2 USA Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
5.3 Canada Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
5.4 Mexico Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
6 Europe Transdermal Drug Delivery System Revenue by Countries
6.1 Europe Transdermal Drug Delivery System Revenue by Countries (2013-2018)
6.2 Germany Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
6.3 UK Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
6.4 France Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
6.5 Russia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
6.6 Italy Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Transdermal Drug Delivery System Revenue by Countries
7.1 Asia-Pacific Transdermal Drug Delivery System Revenue by Countries (2013-2018)
7.2 China Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
7.3 Japan Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
7.4 Korea Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
7.5 India Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
8 South America Transdermal Drug Delivery System Revenue by Countries
8.1 South America Transdermal Drug Delivery System Revenue by Countries (2013-2018)
8.2 Brazil Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
8.3 Argentina Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
8.4 Colombia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Transdermal Drug Delivery System by Countries
9.1 Middle East and Africa Transdermal Drug Delivery System Revenue by Countries (2013-2018)
9.2 Saudi Arabia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
9.3 UAE Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
9.4 Egypt Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
9.5 Nigeria Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
9.6 South Africa Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
10 Global Transdermal Drug Delivery System Market Segment by Type
10.1 Global Transdermal Drug Delivery System Revenue and Market Share by Type (2013-2018)
10.2 Global Transdermal Drug Delivery System Market Forecast by Type (2018-2023)
10.3 Fentanyl Revenue Growth Rate (2013-2023)
10.4 Nitroglycerin Revenue Growth Rate (2013-2023)
10.5 Estradiol Revenue Growth Rate (2013-2023)
10.6 Nicotine Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 Global Transdermal Drug Delivery System Market Segment by Application
11.1 Global Transdermal Drug Delivery System Revenue Market Share by Application (2013-2018)
11.2 Transdermal Drug Delivery System Market Forecast by Application (2018-2023)
11.3 OTC Revenue Growth (2013-2018)
11.4 Rx Revenue Growth (2013-2018)
12 Global Transdermal Drug Delivery System Market Size Forecast (2018-2023)
12.1 Global Transdermal Drug Delivery System Market Size Forecast (2018-2023)
12.2 Global Transdermal Drug Delivery System Market Forecast by Regions (2018-2023)
12.3 North America Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
12.4 Europe Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
12.6 South America Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Transdermal Drug Delivery System Picture
Table Product Specifications of Transdermal Drug Delivery System
Table Global Transdermal Drug Delivery System and Revenue (Million USD) Market Split by Product Type
Figure Global Transdermal Drug Delivery System Revenue Market Share by Types in 2017
Figure Fentanyl Picture
Figure Nitroglycerin Picture
Figure Estradiol Picture
Figure Nicotine Picture
Figure Other Picture
Table Global Transdermal Drug Delivery System Revenue (Million USD) by Application (2013-2023)
Figure Transdermal Drug Delivery System Revenue Market Share by Applications in 2017
Figure OTC Picture
Figure Rx Picture
Table Global Market Transdermal Drug Delivery System Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2013-2023)
Table Hisamitsu Basic Information, Manufacturing Base and Competitors
Table Hisamitsu Transdermal Drug Delivery System Type and Applications
Table Hisamitsu Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Transdermal Drug Delivery System Type and Applications
Table Mylan Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Transdermal Drug Delivery System Type and Applications
Table GSK Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Transdermal Drug Delivery System Type and Applications
Table Novartis Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Teve (Actavis) Basic Information, Manufacturing Base and Competitors
Table Teve (Actavis) Transdermal Drug Delivery System Type and Applications
Table Teve (Actavis) Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Transdermal Drug Delivery System Type and Applications
Table Johnson & Johnson Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Lohmann Basic Information, Manufacturing Base and Competitors
Table Lohmann Transdermal Drug Delivery System Type and Applications
Table Lohmann Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table Teikoku Seiyaku Transdermal Drug Delivery System Type and Applications
Table Teikoku Seiyaku Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Transdermal Drug Delivery System Type and Applications
Table Bayer Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Lingrui Basic Information, Manufacturing Base and Competitors
Table Lingrui Transdermal Drug Delivery System Type and Applications
Table Lingrui Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Transdermal Drug Delivery System Type and Applications
Table Sanofi Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Qizheng Basic Information, Manufacturing Base and Competitors
Table Qizheng Transdermal Drug Delivery System Type and Applications
Table Qizheng Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Endo Basic Information, Manufacturing Base and Competitors
Table Endo Transdermal Drug Delivery System Type and Applications
Table Endo Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Huarun 999 Basic Information, Manufacturing Base and Competitors
Table Huarun 999 Transdermal Drug Delivery System Type and Applications
Table Huarun 999 Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Haw Par Basic Information, Manufacturing Base and Competitors
Table Haw Par Transdermal Drug Delivery System Type and Applications
Table Haw Par Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Nichiban Basic Information, Manufacturing Base and Competitors
Table Nichiban Transdermal Drug Delivery System Type and Applications
Table Nichiban Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Mentholatum Company Basic Information, Manufacturing Base and Competitors
Table Mentholatum Company Transdermal Drug Delivery System Type and Applications
Table Mentholatum Company Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table Laboratoires Genevrier Transdermal Drug Delivery System Type and Applications
Table Laboratoires Genevrier Transdermal Drug Delivery System Revenue, Gross Margin and Market Share (2016-2017)
Table Global Transdermal Drug Delivery System Revenue (Million USD) by Players (2013-2018)
Table Global Transdermal Drug Delivery System Revenue Share by Players (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Share by Players in 2016
Figure Global Transdermal Drug Delivery System Revenue Share by Players in 2017
Figure Global Top 5 Players Transdermal Drug Delivery System Revenue Market Share in 2017
Figure Global Top 10 Players Transdermal Drug Delivery System Revenue Market Share in 2017
Figure Global Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Transdermal Drug Delivery System Revenue (Million USD) by Regions (2013-2018)
Table Global Transdermal Drug Delivery System Revenue Market Share by Regions (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Market Share by Regions (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Market Share by Regions in 2017
Figure North America Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Europe Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure South America Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table North America Transdermal Drug Delivery System Revenue by Countries (2013-2018)
Table North America Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure North America Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure North America Transdermal Drug Delivery System Revenue Market Share by Countries in 2017
Figure USA Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Canada Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Mexico Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table Europe Transdermal Drug Delivery System Revenue (Million USD) by Countries (2013-2018)
Figure Europe Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure Europe Transdermal Drug Delivery System Revenue Market Share by Countries in 2017
Figure Germany Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure UK Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure France Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Russia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Italy Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Transdermal Drug Delivery System Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Countries in 2017
Figure China Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Japan Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Korea Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure India Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table South America Transdermal Drug Delivery System Revenue by Countries (2013-2018)
Table South America Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure South America Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure South America Transdermal Drug Delivery System Revenue Market Share by Countries in 2017
Figure Brazil Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Argentina Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Colombia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Transdermal Drug Delivery System Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Countries in 2017
Figure Saudi Arabia Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure UAE Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Egypt Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure Nigeria Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Figure South Africa Transdermal Drug Delivery System Revenue and Growth Rate (2013-2018)
Table Global Transdermal Drug Delivery System Revenue (Million USD) by Type (2013-2018)
Table Global Transdermal Drug Delivery System Revenue Share by Type (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Share by Type (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Share by Type in 2017
Table Global Transdermal Drug Delivery System Revenue Forecast by Type (2018-2023)
Figure Global Transdermal Drug Delivery System Market Share Forecast by Type (2018-2023)
Figure Global Fentanyl Revenue Growth Rate (2013-2018)
Figure Global Nitroglycerin Revenue Growth Rate (2013-2018)
Figure Global Estradiol Revenue Growth Rate (2013-2018)
Figure Global Nicotine Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Transdermal Drug Delivery System Revenue by Application (2013-2018)
Table Global Transdermal Drug Delivery System Revenue Share by Application (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Share by Application (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue Share by Application in 2017
Table Global Transdermal Drug Delivery System Revenue Forecast by Application (2018-2023)
Figure Global Transdermal Drug Delivery System Market Share Forecast by Application (2018-2023)
Figure Global OTC Revenue Growth Rate (2013-2018)
Figure Global Rx Revenue Growth Rate (2013-2018)
Figure Global Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Transdermal Drug Delivery System Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Transdermal Drug Delivery System Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
Figure Europe Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
Figure South America Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Transdermal Drug Delivery System Revenue Market Forecast (2018-2023)
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Services |
Pages : 123 |
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Services |
Pages : 174 |
Request Sample 
Request Discount 
Inquire Before Buy
